Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events

Since 1996, the scientific community has become aware of 14 reports of yellow fever vaccine (YEL)-associated viscerotropic disease (YEL-AVD) cases and four reports of YEL-associated neurotropic disease (YEL-AND) worldwide, changing our understanding of the risks of the vaccine. Based on 722 adverse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2005-05, Vol.23 (25), p.3256-3263
Hauptverfasser:	Khromava, Alena Y., Eidex, Rachel Barwick, Weld, Leisa H., Kohl, Katrin S., Bradshaw, Robert D., Chen, Robert T., Cetron, Martin S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Adverse drug reaction reporting systems Age Age Factors Age groups Aged Applied microbiology Arboviroses Armed forces Biological and medical sciences Cardiovascular disease Child Child, Preschool Confidence intervals Disease control Family medical history Female Fever Fundamental and applied biological sciences. Psychology Hepatitis Hepatitis A Vaccines - adverse effects Human viral diseases Humans Infant Infectious diseases Logistic Models Male Medical sciences Microbiology Middle Aged Military Personnel Nervous System Diseases - etiology Population Surveillance Ratios Risk Factors Travel Tropical viral diseases Typhoid-Paratyphoid Vaccines - adverse effects United States - epidemiology Vaccination/adverse effects Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vector-borne diseases Viral diseases Yellow fever Yellow fever vaccine Yellow Fever Vaccine - adverse effects Yellow fever virus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!